The combination of soluble mediator levels and anti-nuclear antibody (ANA) positivity increased the accuracy of the prediction of developing SLE compared to ANA positivity alone and to IL-5 and IL-6 levels (84%, 58.55, and 79%, respectively). The gene discussed is IL6; the disease is systemic lupus erythematosus.